- NIH acknowledges KEI/UACT request to use royalty-free or march-in rights on Xtandi
- Feasibility study on a TDR pooled fund for R&D to be released on 20 February 2016
- SAVE THE DATE - 26 January 2016: Implications of the TPP and RCEP on Universal Health Coverage
- Xtandi 2016 March-In Request
- Knowledge Ecology International joins amicus brief on non-copyrightability of model laws and statutes
- 51 members of Congress have asked the NIH to use March-In rights to rein in high drug prices
- WHO's evaluation of the global strategy and plan of action on public health, innovation and intellectual property
- FDA approves 45 new drugs. 47 percent qualify for 50 percent Orphan Drug tax credit
- KEI's December 19, 2015 submission to the US ITC regarding the TPP
- The UK's rebates on drug sales, and introducing the budget constraint into pricing models
Earlier this month, the European Parliament and the European Commission released a new compromise text on orphan works.
The Compromise Text is available here:
KEI sees the text as a step backwards for access to knowledge. The proposed directive makes far too many compromises, is too limited in terms of the beneficiaries and uses of works, and creates complicated, burdensome and costly procedures and record keeping requirements.
Background on earlier EU consultations
The governments of Brunei, Chile, New Zealand, Singapore, Australia, Malaysia, Peru, Vietnam and the United States are negotiating a multilateral free trade agreement known as the Trans-Pacific Partnership Agreement (TPP). The negotiations are being conducted with considerable secrecy, even though they address many issues of great interest to the general public. The Agreement will cover many topics, including intellectual property rights, the pricing of pharmaceutical drugs, and the rights of investors to sue states over policies and actions that impact their investments.
AUD $2 million Australia-WIPO MOU targets TIGAR, neglected diseases, developing IP systems and technology transferSubmitted by thiru on 26. June 2012 - 5:37
On 15 June 2012, the World Intellectual Property Organization and the Australian Permanent Mission to the World Trade Organization signed an agreement and released a joint communiqué "detailing how an AUD$2 million Australian contribution would assist least-developed and developing countries improve their intellectual property systems".
Clearly WIPO could teach a few things to many agencies --other UN bodies but also for example the office of the US Trade Representatives-- regarding transparency and accessibility for all stakeholders.
The Global Fund just sent an email, which says that "your website which inaccurately reports that Mr Steiger will run VPP." Here is the Global Fund email:
From: Andrew Hurst
Date: June 20, 2012 5:36:49 PM GMT+02:00
To: Thirukumaran Balasubramaniam
Subject: RE: Question on the Global Fund's Voluntary Pooled Procurement?
Further to our conversation this week, here is our statement:
On Friday, June 15, 2012, Knowledge Ecology International (KEI) and Universities Allied for Essential Medicines (UAEM) filed as amici curiae in the case Association for Molecular Pathology, et. al. v. United States Patent and Trademark Office, et. al which is currently being heard before the Court of Appeals for the Federal Circuit. The full brief is available for download here.
The language in S. 3187, calling for National Academies evaluation of Medical Innovation inducement prizesSubmitted by James Love on 12. June 2012 - 9:07
SEC. 906. INDEPENDENT STUDY ON MEDICAL INNOVATION INDUCEMENT MODEL.
This statement was delivered by Ecuador on 5 June 2012 at the WTO TRIPS Council on copyright limitations and exceptions.
CONSEJO DE LOS ADPIC
5-6 DE JUNIO DE 2012
PUNTO L. DE LA AGENDA
INTERVENCIÓN DEL ECUADOR
El Ecuador da la bienvenida a la iniciativa organizada por Brasil y Estados Unidos con respecto al punto L. sobre las limitaciones y excepciones a los derechos de autor en el marco de las negociaciones en curso en la OMPI.
I recently sent the following letter to Andrew Bast, the editor of Foreign Affairs. The letter responds to a May 24, 2012 article by Devi Sridhar, Lawrence O.
This statement was delivered by Chile on 5 June 2012 at the WTO TRIPS Council on copyright limitations and exceptions.
AGENDA L COPYRIGHT LIMITATIONS AND EXCEPTIONS
Statement by Brazil at June 2012 WTO TRIPS Council on the state of play of WIPO negotiations on a Treaty for the BlindSubmitted by thiru on 7. June 2012 - 5:04
This was the statement delivered by Brazil on 5 June 2012 at the WTO Council for TRIPS under Agenda Item L-Copyright Limitations and Exceptions: Ongoing Negotiations At WIPO-Briefing By Brazil and the United States.
The following is the Brazilian intervention.
Last April, the President of Brazil, Dilma Rousseff, visited the United States.
The USPTO/DOC's liberal and misleading definition of IP-Intensive industries is designed to influence policy debatesSubmitted by James Love on 6. June 2012 - 7:07
At yesterday's TACD event, USPTO and KEI discussed the report by the Department of Commerce's Economics and Statistics Administration and the United States Patent and Trademark Office on Intellectual Property and employment. The report, titled: Intellectual Property and the U.S. Economy: Industries in Focus, has been widely quoted, including these bullets from its executive summary:
- IP-intensive industries accounted for about $5.06 trillion in value added, or 34.8 percent of U.S. gross domestic product (GDP), in 2010.
5 June 2012: India's statement at WTO TRIPS Council: Exchange of information on securing supply chains against counterfeit goodsSubmitted by thiru on 6. June 2012 - 2:43
On 5 June 2012, India delivered the following intervention at the WTO Council for TRIPS on agenda item K, "Exchange of information on securing supply chains against counterfeit goods".
Intervention on Agenda Item K
(WHO donors) Gates Foundation, US, UK, Canada, Rotary Int., Norway and GAVI: Setting the agenda for global public health?Submitted by thiru on 4. June 2012 - 1:45
In preparation for the 65th World Health Assembly, held in Geneva from 21 May 2012 to 26 May 2012, the World Health Organization (WHO) prepared a document (A65/29 Add. 1, 5 April 2012) entitled "Voluntary contributions by fund and by donor for the financial period 2010-2011.
This is a rough list of the recent ICE press releases mentioning counterfeit and pharmaceutical. It is quite clear that the overwhelming majority of counterfeit busts involve Viagra and other erectile dysfunction drugs, a problem that will probably resolve itself once the Pfizer patents on Viagra expire.
In my quick read of the ICE press releases, I found just 12 pharmaceutical counterfeiting cases in the ICE press releases from 2009 to May 2012, with 14 defendants.
- 13 of the 14 defendants were men.